Search Results - "Erlikh, Alexey D."
-
1
Abstract 162: Evolution of Acute Coronary Syndrome Treatment During Last Years in Russian Hospitals (Based on Results of RECORDs Registries)
Published in Circulation Cardiovascular quality and outcomes (01-03-2017)“…Abstract only Background and Purpose: The prospective registries are the most powerful evaluation tool to characterize patients and features of acute coronary…”
Get full text
Journal Article -
2
Sodium-glucose co-transporter-2 inhibitors in patients with heart failure. What's new? What are the prospects?
Published in Consilium medicum (Online) (2021)“…This review presents the main results of recently (in 2020) published clinical studies investigating additional properties of drugs of the family of…”
Get full text
Journal Article -
3
Abstract 215: The Treatment Quality of Patients With Non-ST Elevation Acute Coronary Syndrome: Association With In-hospital Outcomes, Predictors of Nonconformity With Guidelines
Published in Circulation Cardiovascular quality and outcomes (01-03-2017)“…Abstract only Background: It is known that closer adherence to clinical guidelines for management of acute coronary syndrome (ACS) is associated with better…”
Get full text
Journal Article -
4
Abstract 18269: Invasive Treatment of ST-Elevation Acute Coronary Syndrome in Russian Hospitals is Predominantly Used in Lower Risk Patients
Published in Circulation (New York, N.Y.) (20-11-2012)“…Abstract only Introduction . Inhospital mortality of patients with ST-elevation (STE) acute coronary syndrome (ACS) in Russia is generally very high while it…”
Get full text
Journal Article -
5
Non-immunogenic recombinant staphylokinase versus alteplase for patients with massive pulmonary embolism: a randomized open-label, multicenter, parallel-group, non-inferiority trial, FORPE
Published in Journal of thrombosis and haemostasis (23-10-2024)“…Non-immunogenic staphylokinase is a modified recombinant staphylokinase with low immunogenicity, high thrombolytic activity, and fibrin selectivity. To assess…”
Get full text
Journal Article -
6
Non-immunogenic recombinant staphylokinase versus alteplase for patients with massive pulmonary embolism: a randomised open-label, multicentre, parallel-group, non-inferiority trial FORPE
Published in Journal of thrombosis and haemostasis (23-10-2024)“…Non-immunogenic staphylokinase is a modified recombinant staphylokinase with low immunogenicity, high thrombolytic activity, and fibrin selectivity. To assess…”
Get full text
Journal Article